Cargando…

Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma

Aberrant expression of proteins involved in cell division is a constant feature in multiple myeloma (MM), especially in high-risk disease. Increasingly, therapy of myeloma is moving towards individualization based on underlying genetic abnormalities. Aurora kinases are important mediators of cell cy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Painuly, Utkarsh, Ramakrishnan, Vijay, Kimlinger, Teresa, Wellik, Linda, Haug, Jessica, Gonsalves, Wilson, Bi, Lintao, Huang, Zhongxia, Rajkumar, S. Vincent, Kumar, Shaji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195373/ https://www.ncbi.nlm.nih.gov/pubmed/30349651 http://dx.doi.org/10.18632/oncotarget.26180

Ejemplares similares

Anti-Myeloma Activity of Akt Inhibition Is Linked to the Activation Status of PI3K/Akt and MEK/ERK Pathway
por: Ramakrishnan, Vijay, et al.
Publicado: (2012)

Inhibitor of Apoptosis Proteins (IAPs) as therapeutic targets in Multiple Myeloma (MM)
por: Ramakrishnan, Vijay, et al.
Publicado: (2014)

Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myeloma
por: Ramakrishnan, Vijay, et al.
Publicado: (2016)

Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma
por: Ramakrishnan, Vijay G., et al.
Publicado: (2019)

Efficacy of Bortezomib as First-Line Treatment for Patients with Multiple Myeloma
por: Painuly, Utkarsh, et al.
Publicado: (2013)

Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
por: Tandon, Nidhi, et al.
Publicado: (2016)

Aurora Kinases and Potential Medical Applications of Aurora Kinase Inhibitors: A Review
por: Gavriilidis, Paschalis, et al.
Publicado: (2015)

Multiple myeloma current treatment algorithms
por: Rajkumar, S. Vincent, et al.
Publicado: (2020)

Functional Significance of Aurora Kinases–p53 Protein Family Interactions in Cancer
por: Sasai, Kaori, et al.
Publicado: (2016)

Natural history of multiple myeloma with de novo del(17p)
por: Lakshman, Arjun, et al.
Publicado: (2019)

Aurora kinases in ovarian cancer
por: Pérez-Fidalgo, J Alejandro, et al.
Publicado: (2020)

Aurora at the pole and equator: overlapping functions of Aurora kinases in the mitotic spindle
por: Hochegger, Helfrid, et al.
Publicado: (2013)

Clinicopathological significance and potential drug target of p15(INK4B) in multiple myeloma
por: Li, Jun, et al.
Publicado: (2014)

Molecular signatures of multiple myeloma progression through single cell RNA-Seq
por: Jang, Jin Sung, et al.
Publicado: (2019)

Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC
por: Lin, Zhong-Zhe, et al.
Publicado: (2010)

In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myeloma
por: Mitra, Amit Kumar, et al.
Publicado: (2020)

Aurora kinases in childhood acute leukemia: the promise of aurora B as therapeutic target
por: Hartsink-Segers, S A, et al.
Publicado: (2013)

The Aurora Kinases in Cell Cycle and Leukemia
por: Goldenson, Benjamin, et al.
Publicado: (2014)

Ubiquitin-Mediated Degradation of Aurora Kinases
por: Lindon, Catherine, et al.
Publicado: (2016)

Nuclear localisation of Aurora-A: its regulation and significance for Aurora-A functions in cancer
por: Naso, Francesco Davide, et al.
Publicado: (2021)

Pharmacophore Synergism in Diverse Scaffold Clinches in Aurora Kinase B
por: Masand, Vijay H., et al.
Publicado: (2022)

Functional interplay between NF-κB-inducing kinase and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma
por: Mazzera, Laura, et al.
Publicado: (2019)

Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins
por: Carmena, Mar, et al.
Publicado: (2009)

Computational completion of the Aurora interaction region of N-Myc in the Aurora a kinase complex
por: Altiner, Pinar, et al.
Publicado: (2023)

Metabolomic and Lipidomic Profiling of Bone Marrow Plasma Differentiates Patients with Monoclonal Gammopathy of Undetermined Significance from Multiple Myeloma
por: Gonsalves, Wilson I., et al.
Publicado: (2020)

Smoldering multiple myeloma current treatment algorithms
por: Rajkumar, S. Vincent, et al.
Publicado: (2022)

Aurora kinase inhibitors: Progress towards the clinic
por: Kollareddy, Madhu, et al.
Publicado: (2012)

Aurora Kinase Inhibitors: Current Status and Outlook
por: Bavetsias, Vassilios, et al.
Publicado: (2015)

Functions of Aurora kinase C in meiosis and cancer
por: Quartuccio, Suzanne M., et al.
Publicado: (2015)

The multifaceted allosteric regulation of Aurora kinase A
por: Levinson, Nicholas Mark
Publicado: (2018)

Aurora kinases: novel therapy targets in cancers
por: Tang, Anqun, et al.
Publicado: (2017)

Aurora A Protein Kinase: To the Centrosome and Beyond
por: Magnaghi-Jaulin, Laura, et al.
Publicado: (2019)

Selective Disruption of Aurora C Kinase Reveals Distinct Functions from Aurora B Kinase during Meiosis in Mouse Oocytes
por: Balboula, Ahmed Z., et al.
Publicado: (2014)

Expression and clinical significance of FGFR1 and FGFR2 in laryngeal squamous cell carcinoma
por: Hu, Mengdie, et al.
Publicado: (2022)

Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma
por: Binder, M, et al.
Publicado: (2016)

P-208: Association of thrombocytopenia with disease burden, high-risk cytogenetics, and survival in newly diagnosed multiple myeloma patients
por: Charalampous, Charalampos, et al.
Publicado: (2022)

Novel molecular subgroups within the context of receptor tyrosine kinase and adhesion signalling in multiple myeloma
por: Leich, Ellen, et al.
Publicado: (2021)

Biological Significance and Targeting of the FGFR Axis in Cancer
por: Chioni, Athina-Myrto, et al.
Publicado: (2021)

Cdc7 kinase stimulates Aurora B kinase in M-phase
por: Ito, Sayuri, et al.
Publicado: (2019)

Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer
por: UMENE, KIYOKO, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_k7adrc6q4qrehg86gt0cbubi36